GWSG
RIGL icon

GPS Wealth Strategies Group’s Rigel Pharmaceuticals RIGL Stock Holding History

GPS Wealth Strategies Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50
Closed -$1.42K – 1351
2025
Q3 		$1.42K Hold
50
– – ﹤0.01% 1444
2025
Q2 		$937 Hold
50
– – ﹤0.01% 1433
2025
Q1 		$900 Buy
+50
New +$1.01K ﹤0.01% 1379

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GPS Wealth Strategies Group's RIGL Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of Rigel Pharmaceuticals (RIGL) in Q4 2025, closing a stake of 50 shares — an estimated $1.42K sold.

GPS Wealth Strategies Group first reported a position in RIGL in Q1 2025 and held it in 3 quarters. The position peaked at $1.42K in Q3 2025. 193 funds tracked by Wall St. Rank hold RIGL as of Q4 2025.

  • GPS Wealth Strategies Group reported no remaining Rigel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 50 Rigel Pharmaceuticals shares in Q4 2025, an estimated $1.42K.
  • GPS Wealth Strategies Group first reported a position in Rigel Pharmaceuticals in Q1 2025 and held it in 3 quarters.
  • GPS Wealth Strategies Group's Rigel Pharmaceuticals position peaked at $1.42K in Q3 2025.
  • 193 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.